
Fortis Healthcare Ltd. share price
NSE: FORTIS · Healthcare
₹803.20 +5.13%
Closing price data, updated 17 Nov 2026. 52-week range: -20.5% from high, +13.9% above low.
Price₹803.20
Market cap₹60,638 Cr
P/E58.4
P/B5.79
ROE11.1%
ROCE11.9%
Debt / equity0.35
Dividend yield0.00%
EPS₹13.75
Book value₹138.79
Operating margin17.8%
Dipscan score42 / 100
Share: WhatsAppX / TwitterTelegram
Fortis Healthcare Ltd. shareholding pattern
As of Sep 2026: Promoters 31.17%, FIIs 23.19%, DIIs 34.46%, Government 0.00%, Public 9.80%, Others 1.38%.
| Holder | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|---|
| Promoters | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% |
| FIIs | 23.19% | 25.20% | 25.97% | 27.84% | 27.90% | 27.17% |
| DIIs | 34.46% | 32.23% | 31.35% | 29.33% | 29.14% | 29.79% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 9.80% | 9.87% | 9.96% | 10.14% | 10.14% | 10.17% |
| Others | 1.38% | 1.53% | 1.54% | 1.53% | 1.65% | 1.70% |
| No. of Shareholders | 217,704 | 220,743 | 226,685 | 233,156 | 220,766 | 205,373 |
As filed by the company with the exchanges.
Returns
| 1 day | 1 week | 1 month | 3 months | 6 months | 1 year |
|---|---|---|---|---|---|
| +5.13% | +4.73% | +7.09% | -11.36% | -17.25% | -18.61% |
Growth
| Sales growth, 3 years | +13.3% |
| Sales growth, 5 years | – |
| Profit growth, 3 years | +20.9% |
| Profit growth, 5 years | – |
| Latest quarter sales vs last year | +17.3% |
| Latest quarter profit vs last year | -3.0% |
Strengths and weaknesses
Strengths
- Company has delivered good profit growth of 64.3% CAGR over last 5 years
Weaknesses
- Stock is trading at 5.79 times its book value
- Company has a low return on equity of 9.87% over last 3 years.
Peers in Healthcare
| Company | Price | Market cap | P/E | ROE | 1 year |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | ₹1,867.50 | ₹4,48,076 Cr | 40.9 | 14.7% | +8.8% |
| Divi's Laboratories Ltd. | ₹11,080.00 | ₹2,94,139 Cr | 87.5 | 16.2% | +69.4% |
| Torrent Pharmaceuticals Ltd. | ₹4,691.20 | ₹1,78,438 Cr | 84.0 | 27.1% | +22.6% |
| Apollo Hospitals Enterprise Lt | ₹8,771.00 | ₹1,26,114 Cr | 56.2 | 21.9% | +16.9% |
| Laurus Labs Ltd. | ₹2,220.00 | ₹1,19,949 Cr | 89.5 | 18.2% | +125.2% |
| Zydus Lifesciences Ltd. | ₹1,192.00 | ₹1,18,902 Cr | 28.4 | 19.7% | +27.0% |
| Dr. Reddy's Laboratories Ltd. | ₹1,377.90 | ₹1,14,778 Cr | 41.0 | 12.1% | +13.7% |
| Cipla Ltd. | ₹1,394.50 | ₹1,12,658 Cr | 38.9 | 11.8% | -8.0% |
Frequently asked questions
What is the share price of Fortis Healthcare Ltd.?
Fortis Healthcare Ltd. (FORTIS) last closed at ₹803.20 (+5.13% on the day).
What is the market cap of Fortis Healthcare Ltd.?
About ₹60,638 Cr.
What is the P/E ratio of Fortis Healthcare Ltd.?
The price-to-earnings ratio is 58.4, and return on equity is 11.1%.
Figures are calculated from company results and exchange prices and are for information only.